Form 4: American Healthcare REIT Executive Gabriel Willhite Reports Stock Transactions
SEC Form 4 Filing
Gabriel Willhite, Chief Operating Officer of American Healthcare REIT, reports the vesting of restricted stock units and subsequent ownership of Class T Common Stock.
Summary
- On April 3, 2024, Gabriel M. Willhite, Chief Operating Officer of American Healthcare REIT, reported transactions involving the company's securities.
- Willhite acquired 6,767 shares of Class T Common Stock through the vesting of restricted stock units (RSUs).
- These RSUs are part of an award of 20,303 time-based RSUs granted on April 3, 2023, which vest in three equal installments on April 3, 2024, 2025, and 2026, contingent upon continuous employment.
- Following the reported transaction, Willhite directly owns 31,252 shares of Common Stock and 13,536 derivative securities (Restricted Stock Units).
- Willhite also directly owns 125,926 shares of Common Stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as the document simply reports routine insider transactions related to equity compensation.
Positives
- The vesting of RSUs indicates continued employment and alignment of the executive's interests with the company's performance.
Future Outlook
The remaining RSUs will vest in two equal installments on April 3, 2025, and April 3, 2026, subject to continuous employment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Comparison to Industry Standards
- Equity compensation is a common practice in the real estate industry, particularly for REITs, to align management's interests with those of shareholders.
- Companies like Welltower (WELL) and Ventas (VTR) also utilize restricted stock units as part of their executive compensation packages.
- The vesting schedules and amounts are generally benchmarked against peer companies to ensure competitive compensation.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns management's interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 04/03/2023 | Date the Issuer awarded the Reporting Person 20,303 time-based restricted stock units ('RSUs'). |
| 04/03/2024 | Date of transaction: vesting of 6,767 restricted stock units. |
| 04/03/2024 | First vesting date of RSUs. |
| 04/05/2024 | Date of signature for the Form 4 filing. |
| 04/03/2025 | Second vesting date of RSUs. |
| 04/03/2026 | Third vesting date of RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.